Agalsidase beta
Fabrazyme (agalsidase beta) is an enzyme pharmaceutical. Agalsidase beta was first approved as Fabrazyme on 2001-08-03. It is used to treat fabry disease in the USA. It has been approved in Europe to treat fabry disease.
| Trade Name | Fabrazyme |
|---|---|
| Common Name | Agalsidase beta |
| Indication | fabry disease |
| Drug Class | Enzymes |
